NCT00270634 Study of ISA247 (Voclosporin) in De Novo Renal Transplantation Status COMPLETED Phase PHASE2
NCT00263328 Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient Status COMPLETED Phase PHASE2
NCT00262886 Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00261820 Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients Status COMPLETED Phase PHASE4
NCT00260208 Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus Status TERMINATED Phase PHASE4
NCT00255710 Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer Status COMPLETED Phase PHASE1
NCT00240994 Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients Status COMPLETED Phase PHASE2
NCT00223054 Polymorphism of the Cytochrome P450-system in Renal Transplants Status COMPLETED Phase N/A
NCT00204191 Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation Status UNKNOWN Phase PHASE4
NCT00203281 Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis Status WITHDRAWN Phase N/A
NCT00195429 A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients Status COMPLETED Phase PHASE4
NCT00189839 A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation Status COMPLETED Phase PHASE3
NCT00189826 A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation. Status COMPLETED Phase PHASE3
NCT00189787 Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma Status COMPLETED Phase PHASE2
NCT00189761 A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients Status COMPLETED Phase PHASE2
NCT00189748 A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension- Status COMPLETED Phase PHASE2
NCT00189722 Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma Status COMPLETED Phase PHASE2
NCT00183248 Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients Status COMPLETED Phase PHASE1/PHASE2